Answer
Larotrectinib is licensed only when a validated test confirms that the tumour contains an NTRK gene fusion.
Sources for this answer
- VITRAKVI 100 mg hard capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.